|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.01.26 - 13:03
|
Neogen Announces Second-Quarter 2026 Results (Business Wire)
|
|
|
Revenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY
Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million
Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially
Company hires key senior commercial leaders
Petrifilm manufacturing transition remains on track
Raising FY 2026 revenue and Adjusted EBITDA guidance
1 Non-GAAP financial measures; see explanations and reconciliations that followLANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025.
“I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and profitability in the second quarter,” said Mike Nassi...
|
|
|
|
|
|
|
|
|
05.01.26 - 14:51
|
Neogen® Announces Two Senior Leadership Appointments (Business Wire)
|
|
|
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026.
As Senior Vice President and General Manager for Neogen's Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen's global Food Safety portfolio and will develop and execute the global strategy for continued innovation and growth, including marketing, research and development, and government and regulatory affairs. She joins Neogen from QuidelOrtho, where she served as Senior Vice President and General Manager for the company's molecular diagnostics and point-of-care business units.
As Senior Vice President and Chief Commercial Officer, Mr. Freels will lead Neogen's global Food Safety commercial strategy, including sales, customer and technical services, regional marke...
|
|
|
18.12.25 - 15:06
|
Neogen Announces Second-Quarter Earnings Release Date (Business Wire)
|
|
|
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on January 8, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time, to discuss the financial results.
The conference call can be accessed by dialing:
Toll-Free - North America: 1-800-549-8228
International: (+1) 646-564-2877
Conference ID: 82072
The live webcast can be accessed through Neogen's Investor Relations webpage, investors.neogen.com, under the “Events & Presentations” subheading.
A replay of the conference call and webcast will be available shortly following the conclusion of the call and can be accessed by dialing:
Toll-Free - North America: 1-888-660-6264
International: (+1) 646-517-3975
Passcode: 82072 #
It will also be available on Neogen's Investor Relations website at investors.neogen.com.
About Neogen
Neogen Corporation is committed to fueling a brighter future...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30.10.25 - 13:51
|
Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer (Business Wire)
|
|
|
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), a global leader of food safety solutions, is pleased to announce the appointment of Bryan Riggsbee as its new Chief Financial Officer effective November 3, 2025. Riggsbee will oversee Neogen's global finance organization and join the company's Executive Leadership Team, reporting directly to Chief Executive Officer Mike Nassif. To ensure a smooth transition, David Naemura is expected to remain with the Company until the end of the calendar year.
Riggsbee brings over 25 years of financial leadership experience across the diagnostics and healthcare industries. He joins Neogen from bioMérieux where he served as Chief Financial Officer of its $2 billion North American business. Prior to that, Riggsbee spent nearly a decade as Chief Financial Officer at Myriad Genetics, where he led the company's finance, accounting, and investor relations functions and played a key role in expanding the company's portfolio and partnerships, as well as ...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
